Comparison of the lipoprotein and hemostatic changes after a triphasic and a monophasic low dose oral contraceptive in premenopausal middle-aged women

This publication has 48 references indexed in Scilit:

• STROKE PREVENTION AND OESTROGEN REPLACEMENT
  The Lancet, 1989
• Contraceptive steroid effects on lipids and lipoproteins in cynomolgus monkeys.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
• Reduced HDL2 levels in myocardial infarction patients without risk factors for atherosclerosis
  Atherosclerosis, 1987
• Effects of Serum from Oral Contraceptive Users on the Metabolism of Low Density Lipoprotein
  The Lancet Healthy Longevity, 1987
• Apolipoprotein A-IMilano. Correlation between high density lipoprotein subclass distribution and triglyceridemia.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
• The effects of estrogen on apolipoprotein synthesis
  Canadian Journal of Biochemistry and Cell Biology, 1985
• Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy.
  Journal of Clinical Investigation, 1985
• Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein Cholesterol
  New England Journal of Medicine, 1983
• Norethindrone acetate inhibition of triglyceride synthesis and release by rat hepatocytes
  Atherosclerosis, 1983
• HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGEN
  The Lancet, 1977